APA (7th ed.) Citation

M, C., S, S., F, G., GM, B., GL, C., A, A., . . . E, O. (2025). Predictors and benefits of lipid-lowering therapy initiation after an atherosclerotic cardiovascular event: A retrospective cohort study. Frontiers in pharmacology, 16, 1588376. https://doi.org/10.3389/fphar.2025.1588376

Chicago Style (17th ed.) Citation

M, Casula, Scotti S, Galimberti F, Bruno GM, Colombo GL, Alieva A, Xie S, Catapano AL, and Olmastroni E. "Predictors and Benefits of Lipid-lowering Therapy Initiation After an Atherosclerotic Cardiovascular Event: A Retrospective Cohort Study." Frontiers in Pharmacology 16 (2025): 1588376. https://doi.org/10.3389/fphar.2025.1588376.

MLA (9th ed.) Citation

M, Casula, et al. "Predictors and Benefits of Lipid-lowering Therapy Initiation After an Atherosclerotic Cardiovascular Event: A Retrospective Cohort Study." Frontiers in Pharmacology, vol. 16, 2025, p. 1588376, https://doi.org/10.3389/fphar.2025.1588376.